Phreesia Inc

Phreesia Inc

PHR

Get informed when a big investor buys or sells

+ Follow
Market Cap$620.59M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Phreesia IncPhreesia Inc58.3--2%1.30.3
$12.57

Target Price by Analysts

25.7% upsidePhreesia Target Price DetailsTarget Price
$29.73

Current Fair Value

197.3% upside

Undervalued by 197.3% based on the discounted cash flow analysis.

Share Statistics

Market cap$620.59 Million
Enterprise Value$648.84 Million
Dividend Yield$- (-)
Earnings per Share$0.04
Beta0.86
Outstanding Shares61,878,316

Return

Return on Equity-1.58%ROE
Return on Assets-0.91%
Return on Invested Capital1.67%

Valuation & Multiples

P/E Ratio58.3P/E Ratio
PEG9.76PEG
Price to Sales1.25Price to Sales
Price to Book Ratio1.67Price to Book Ratio
Enterprise Value to Revenue1.28
Enterprise Value to EBIT77.13
Enterprise Value to Net Income-111
Total Debt to Enterprise0.16
Debt to Equity0.27Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
September 3, 2026
EPS Estimate
$0.11
Average shareholder expectation
Revenue Estimate
$129.06 M
Average shareholder expectation

Next Earnings Call

Expected Date
December 14, 2026
EPS Estimate
$0.13
Average shareholder expectation
Revenue Estimate
$128.32 M
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio0.2916▼ 317.68%
Total Calls402,600▲ 389.78%
Total Puts117,400▼ 58.82%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %95.06%▼ 1.37%
Total Invested$604.56M▲ 21.89%
Investors Holding237▼ 17.00%

ESG Score

No data

About Phreesia Inc

CEO: Chaim Indig

Phreesia gives healthcare organizations a suite of robust applications to manage the patient intake process. Our innovative SaaS platform engages patients and provides a modern, convenient experience, while enabling our clients to optimi...